SEC Form 4 · accession 0001237899-16-000084
REGENERON PHARMACEUTICALS, INC. · REGN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Arthur F Ryan
Director
Period of report
Nov 15, 2016
Accepted (ET)
Nov 16, 2016 · 4:21 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000872589
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Nov 15, 2016 | S | 2,000 | $429.34 | D | 36,500 | D | |
| Common Stock | Nov 15, 2016 | G | 1,000 | $0.00 | D | 35,500 | D |
Table II — derivative securities
No Table II lines on this filing.